Taiwan · Delayed Price · Currency is TWD Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 4.49 billion. The enterprise value is 4.56 billion.
| Market Cap | 4.49B |
| Enterprise Value | 4.56B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Jun 30, 2026 |
Share Statistics
Onyx Healthcare has 39.07 million shares outstanding. The number of shares has increased by 0.65% in one year.
| Current Share Class | 39.07M |
| Shares Outstanding | 39.07M |
| Shares Change (YoY) | +0.65% |
| Shares Change (QoQ) | -0.53% |
| Owned by Insiders (%) | 12.04% |
| Owned by Institutions (%) | 0.02% |
| Float | 12.30M |
Valuation Ratios
The trailing PE ratio is 31.03.
| PE Ratio | 31.03 |
| Forward PE | n/a |
| PS Ratio | 3.25 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.81 |
| P/FCF Ratio | 186.87 |
| P/OCF Ratio | 117.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.01, with an EV/FCF ratio of 189.66.
| EV / Earnings | 31.44 |
| EV / Sales | 3.30 |
| EV / EBITDA | 26.01 |
| EV / EBIT | 29.75 |
| EV / FCF | 189.66 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.84 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 2.81 |
| Debt / FCF | 12.93 |
| Interest Coverage | 17.58 |
Financial Efficiency
Return on equity (ROE) is 9.02% and return on invested capital (ROIC) is 4.89%.
| Return on Equity (ROE) | 9.02% |
| Return on Assets (ROA) | 2.52% |
| Return on Invested Capital (ROIC) | 4.89% |
| Return on Capital Employed (ROCE) | 4.92% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | 11.51M |
| Profits Per Employee | 1.21M |
| Employee Count | 120 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.85 |
Taxes
In the past 12 months, Onyx Healthcare has paid 21.52 million in taxes.
| Income Tax | 21.52M |
| Effective Tax Rate | 12.95% |
Stock Price Statistics
The stock price has decreased by -2.54% in the last 52 weeks. The beta is 0.27, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -2.54% |
| 50-Day Moving Average | 103.00 |
| 200-Day Moving Average | 110.47 |
| Relative Strength Index (RSI) | 62.58 |
| Average Volume (20 Days) | 166,259 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.38 billion and earned 145.04 million in profits. Earnings per share was 3.71.
| Revenue | 1.38B |
| Gross Profit | 477.85M |
| Operating Income | 88.47M |
| Pretax Income | 166.16M |
| Net Income | 145.04M |
| EBITDA | 103.67M |
| EBIT | 88.47M |
| Earnings Per Share (EPS) | 3.71 |
Balance Sheet
The company has 243.78 million in cash and 310.94 million in debt, with a net cash position of -67.16 million or -1.72 per share.
| Cash & Cash Equivalents | 243.78M |
| Total Debt | 310.94M |
| Net Cash | -67.16M |
| Net Cash Per Share | -1.72 |
| Equity (Book Value) | 1.60B |
| Book Value Per Share | 41.00 |
| Working Capital | 402.03M |
Cash Flow
In the last 12 months, operating cash flow was 38.20 million and capital expenditures -14.15 million, giving a free cash flow of 24.04 million.
| Operating Cash Flow | 38.20M |
| Capital Expenditures | -14.15M |
| Depreciation & Amortization | 15.20M |
| Net Borrowing | 132.75M |
| Free Cash Flow | 24.04M |
| FCF Per Share | 0.62 |
Margins
Gross margin is 34.61%, with operating and profit margins of 6.41% and 10.50%.
| Gross Margin | 34.61% |
| Operating Margin | 6.41% |
| Pretax Margin | 12.03% |
| Profit Margin | 10.50% |
| EBITDA Margin | 7.51% |
| EBIT Margin | 6.41% |
| FCF Margin | 1.74% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.17%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 2.17% |
| Dividend Growth (YoY) | -24.25% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 106.54% |
| Buyback Yield | -0.65% |
| Shareholder Yield | 1.55% |
| Earnings Yield | 3.23% |
| FCF Yield | 0.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 5.21 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.21 |
| Piotroski F-Score | 6 |